Trials / Unknown
UnknownNCT03219944
Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation
Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation Around Implant in the Aesthetic Zone: A Randomized Control Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Platelet Rich Fibrin | : Platelet Rich Fibrin for soft tissue augmentation around implant in the aesthetic zone |
| PROCEDURE | sub epithelial connective tissue graft | sub epithelial connective tissue graft for soft tissue augmentation around implant in the aesthetic zone |
Timeline
- Start date
- 2017-08-15
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2017-07-18
- Last updated
- 2017-07-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03219944. Inclusion in this directory is not an endorsement.